We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$26.4B
AUM Growth
+$634M
Cap. Flow
+$1.1B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.91%
Holding
1,174
New
163
Increased
578
Reduced
215
Closed
152

Sector Composition

Rank Sector Weight
1 Healthcare 23.87%
2 Technology 22.49%
3 Financials 11.08%
4 Consumer Discretionary 10.4%
5 Industrials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLRX icon
801
Pliant Therapeutics
PLRX
$67.5M
$2.1M 0.01%
1,666,830
-359,361
-18% -$454K
UTHR icon
802
United Therapeutics
UTHR
$26.6B
$2.06M 0.01%
3,477
+2,692
+343% +$1.34M
MPWR icon
803
Monolithic Power Systems
MPWR
$64B
$2.04M 0.01%
1,869
-771
-29% -$842K
ZTS icon
804
Zoetis
ZTS
$32.5B
$2.03M 0.01%
17,191
+9,083
+112% +$1.12M
CRWD icon
805
CrowdStrike
CRWD
$188B
$1.97M 0.01%
20,208
-372,492
-95% -$39.5M
TTD icon
806
Trade Desk
TTD
$8.59B
$1.96M 0.01%
86,244
+78,092
+958% +$2.25M
QBTS icon
807
D-Wave Quantum
QBTS
$7.04B
$1.93M 0.01%
+133,617
New +$2.83M
SOLV icon
808
Solventum
SOLV
$14B
$1.91M 0.01%
29,216
+3,909
+15% +$290K
PNW icon
809
Pinnacle West Capital
PNW
$12.8B
$1.89M 0.01%
18,759
+543
+3% +$52.4K
RZLT icon
810
Rezolute
RZLT
$475M
$1.87M 0.01%
611,797
+243,631
+66% +$731K
FDMT icon
811
4D Molecular Therapeutics
FDMT
$541M
$1.86M 0.01%
200,001
AMRZ
812
Amrize Ltd
AMRZ
$27.7B
$1.85M 0.01%
32,953
-205,956
-86% -$11.8M
SAP icon
813
SAP
SAP
$201B
$1.84M 0.01%
+10,768
New +$2.22M
NWSA icon
814
News Corp Class A
NWSA
$14.9B
$1.81M 0.01%
72,682
+8,761
+14% +$217K
GNRC icon
815
Generac Holdings
GNRC
$11.5B
$1.8M 0.01%
9,196
+265
+3% +$50.9K
AKTS
816
Aktis Oncology
AKTS
$1.39B
$1.79M 0.01%
+100,000
New +$1.94M
FERG icon
817
Ferguson
FERG
$45.2B
$1.79M 0.01%
7,654
+4,043
+112% +$984K
MNKD icon
818
MannKind Corp
MNKD
$1.26B
$1.76M 0.01%
+719,134
New +$3.21M
NBP
819
NovaBridge Biosciences American Depositary Shares
NBP
$213M
$1.72M 0.01%
700,000
-350,000
-33% -$1.17M
DIN icon
820
Dine Brands
DIN
$443M
$1.72M 0.01%
65,450
-104,782
-62% -$3.4M
ENGN icon
821
enGene Therapeutics
ENGN
$122M
$1.7M 0.01%
250,000
KR icon
822
Kroger
KR
$35.7B
$1.7M 0.01%
23,444
+11,931
+104% +$807K
NGNE icon
823
Neurogene
NGNE
$685M
$1.69M 0.01%
83,835
PSA icon
824
Public Storage
PSA
$61.3B
$1.67M 0.01%
6,159
+3,271
+113% +$938K
STOK icon
825
Stoke Therapeutics
STOK
$1.84B
$1.63M 0.01%
50,120

Similar funds

Woodline Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Woodline Partners held 1,174 positions worth $26.4B, up 2.5% from $25.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $1.1B of net new capital in Q1 2026, opening 163 new positions and adding to 578 existing holdings. Its largest new stake was SSR Mining: 3,518,756 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Keysight, an estimated $222M trimmed.

  • Woodline Partners's largest Q1 2026 buy was SSR Mining: 3,518,756 shares worth $103M.
  • Woodline Partners added most to Alphabet (Google) Class A in Q1 2026, an estimated $156M increase.
  • Woodline Partners's biggest Q1 2026 reduction was Keysight, cutting an estimated $222M.
  • Woodline Partners fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.01B.
  • Woodline Partners's ten largest holdings make up 17% of its $26.4B portfolio in Q1 2026.
  • Woodline Partners opened 163 new positions and closed 152 in Q1 2026.
  • Woodline Partners's portfolio value rose 2.5% quarter-over-quarter to $26.4B.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.